|Articles|January 1, 2019
- Pharmaceutical Executive-01-01-2019
- Volume 39
- Issue 1
Pharmaceutical Executive, January 2019 Issue (PDF)
Click the title above to open the Pharmaceutical January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Ipsen’s David Meek: Tasked to Transformover 7 years ago
Drug Research and Review Issues on Radar at FDAover 7 years ago
Finding the Right Digital Health Partnerover 7 years ago
Future Pharma: Data Science as a Strategic Partnerover 7 years ago
Ascending the Uncanny Valley in Healthcareover 7 years ago
Country Report: TurkeyNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market
2
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
3
Asembia AXS26 Summit: The Future of High-Cost Specialty Drugs
4
Pharmaceutical Executive Daily: FDA Approves Breztri
5